Sponsored Content
***Tuesday, March 30, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST*** How can real-world data enrich our understanding of patient care and outcomes? A panel of experts will share perspectives on the right role and impact for external control arms on trials, approval and access, including ways RWE can help overcome approval and access barriers. ***On demand available after final airing until Mar. 30, 2022***
Register free: https://www.pharmexec.com/pe_w/learning_system
Event Overview:
The breadth and depth of real-world data today may offer an opportunity to understand patient care and outcomes with more clarity than randomized clinical trials can bring. Study designs are evolving, with external controls playing an increasingly important role in product evaluation, but questions remain around accepted evidentiary standards. Both regulatory and HTA decision-makers are evolving their decision paradigms to fulfill the promise of RWE. This panel discussion will include a lively discussion of:
Key Learning Objectives:
Sponsor: Parexel
Time and Date: Tuesday, March 30, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after final airing until Mar. 30, 2022
Register free: https://www.pharmexec.com/pe_w/learning_system